Prostate Cancer - Results from #2940

Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analy April 11, 2023

Diagnostic Performance of 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography to Monitor Treatment Response in Patients with Metastatic Prostate Cancer: The Concordance Between Biochemical Response and Prostate-specific Membrane Antigen Results. April 11, 2023

Landscape of Prostate-Specific Membrane Antigen Heterogeneity and Regulation in AR-Positive and AR-Negative Metastatic Prostate Cancer April 10, 2023

Trajectory of Depression among Prostate Cancer Patients: A Secondary Analysis of a Randomized Controlled Trial April 10, 2023

Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study. April 10, 2023

Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning. April 10, 2023

Financial toxicity of oral therapies in advanced prostate cancer. April 10, 2023

A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer. April 10, 2023

Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate Lesions. April 10, 2023

Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial. April 10, 2023

Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT? April 7, 2023

Magnetic resonance imaging (MRI) for local staging before salvage radical prostatectomy: a meta-analysis. April 7, 2023

PSMA PET/CT Detection of Chondromyxoid Fibroma. April 7, 2023

Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study. April 7, 2023

Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. April 7, 2023

Novel Immunotherapy Agent Safe, Shows Promise Against High-Risk Prostate Cancers April 6, 2023

Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study. April 6, 2023

Role of Pelvic Drain and Timing of Urethral Catheter Removal Following RARP: A Systematic Review and Meta-analysis. April 6, 2023

Evaluation of Outcomes following Focal Ablative Therapy for Treatment of Localised Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-year Experience. April 6, 2023

Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study. April 6, 2023

Page 148 of 1439